These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3589708)

  • 1. High-dose megestrol acetate for the treatment of advanced breast cancer: dose and toxicities.
    Aisner J; Tchekmedyian NS; Moody M; Tait N
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):48-55. PubMed ID: 3589708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose megestrol acetate in the treatment of advanced breast cancer.
    Tchekmedyian NS; Tait N; Abrams J; Aisner J
    Semin Oncol; 1988 Apr; 15(2 Suppl 1):44-9. PubMed ID: 3368800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer.
    Tchekmedyian NS; Tait N; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):20-5. PubMed ID: 3798125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of megestrol acetate with or without premarin in the treatment of potentially responsive metastatic breast cancer. A Study of the Eastern Cooperative Oncology Group (E2185).
    Cobau CD; Declercq K; Neuberg D; Ingle JN; Tormey DC
    Cancer; 1996 Feb; 77(3):483-9. PubMed ID: 8630955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase I/II study of high-dose megestrol acetate in the treatment of metastatic breast cancer.
    Parnes HL; Abrams JS; Tchekmedyian NS; Tait N; Aisner J
    Breast Cancer Res Treat; 1991 Aug; 18(3):171-7. PubMed ID: 1756260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose megestrol acetate therapy of ovarian carcinoma: a phase II study by the Northern California Oncology Group.
    Sikic BI; Scudder SA; Ballon SC; Soriero OM; Christman JE; Suey L; Ehsan MN; Brandt AE; Evans TL
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):26-32. PubMed ID: 3099393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of megestrol acetate in previously treated patients with advanced breast cancer: relationship of response to previous treatment.
    Blackledge GR; Latief T; Mould JJ; Spooner D; Morrison M
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1091-4. PubMed ID: 2946584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Lentz SS; Brady MF; Major FJ; Reid GC; Soper JT
    J Clin Oncol; 1996 Feb; 14(2):357-61. PubMed ID: 8636744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol acetate: phase II study of a single daily administration in advanced breast cancer.
    Pronzato P; Brema F; Amoroso D; Bertelli G; Conte PF; Martini MC; Pastorino G; Rosso R
    Breast Cancer Res Treat; 1990 Nov; 17(1):51-4. PubMed ID: 2095927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight changes in women with metastatic breast cancer treated with megestrol acetate: a comparison of standard versus high-dose therapy.
    Cruz JM; Muss HB; Brockschmidt JK; Evans GW
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):63-7. PubMed ID: 2259928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antiestrogen and progestogen therapy for initial treatment and consequences of their combination for second-line treatment of recurrent breast cancer.
    Paterson AH; Hanson J; Pritchard KI; Sansregret E; Dahrouge S; McDermot RS; Fine S; White DF; Trudeau M; Stewart DJ
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):52-62. PubMed ID: 2259927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Megestrol acetate versus tamoxifen in advanced breast cancer: 5-year analysis--a phase III trial of the Piedmont Oncology Association.
    Muss HB; Wells HB; Paschold EH; Black WR; Cooper MR; Capizzi RL; Christian R; Cruz JM; Jackson DV; Powell BL
    J Clin Oncol; 1988 Jul; 6(7):1098-106. PubMed ID: 3292710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Megestrol acetate therapy for advanced breast cancer.
    Gregory EJ; Cohen SC; Oines DW; Mims CH
    J Clin Oncol; 1985 Feb; 3(2):155-60. PubMed ID: 3838187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose progestin therapy for metastatic breast cancer.
    Muss HB; Cruz JM
    Ann Oncol; 1992 Aug; 3 Suppl 3():15-20. PubMed ID: 1390312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megestrol acetate in advanced breast carcinoma.
    Espie M
    Oncology; 1994 Oct; 51 Suppl 1():8-12. PubMed ID: 7970508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appetite stimulation with megestrol acetate in cachectic cancer patients.
    Tchekmedyian NS; Tait N; Moody M; Greco FA; Aisner J
    Semin Oncol; 1986 Dec; 13(4 Suppl 4):37-43. PubMed ID: 3798127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High- versus standard-dose megestrol acetate in women with advanced breast cancer: a phase III trial of the Piedmont Oncology Association.
    Muss HB; Case LD; Capizzi RL; Cooper MR; Cruz J; Jackson D; Richards F; Powell BL; Spurr CL; White D
    J Clin Oncol; 1990 Nov; 8(11):1797-805. PubMed ID: 2230868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose megestrol acetate as third-line endocrine therapy for metastatic breast cancer.
    Cruz JM; Muss HB; Russell G
    Oncology; 1992; 49 Suppl 2():8-11. PubMed ID: 1461630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
    Brufman G; Isacson R; Haim N; Gez E; Sulkes A
    Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of high-dose progestins in breast cancer.
    Abrams JS; Parnes H; Aisner J
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):68-72. PubMed ID: 2148027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.